Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer
Respirology · 2024-04 · 29 (4) · 333-339
DOI: 10.1111/resp.14680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, online erschienen am 20.02.2024. Verfasst von Mi-Hyun Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background and Objective Next‐generation sequencing (NGS) analysis is considered standard for lung cancer diagnosis in clinical practice. Little is known about the feasibility of NGS using tumour tissue sampled with a 1.1 mm‐diameter cryoprobe. We aimed to investigate the suitability of specimens obtained by transbronchial cryobiopsy (TBC) using a 1.1 mm‐diameter cryoprobe for NGS analysis.
Methods
Patients with lung cancer who underwent TBC using a 1.1 mm‐diameter cryoprobe for NGS testing between October 2020 and April 2023 were enrolled. A 4.0‐ or 3.0 mm‐diameter bronchoscope with radial probe endobronchial ultrasound and virtual bronchoscopic navigation was used to detect peripheral lung lesions. All procedures were performed under fluoroscopic guidance. Data were analysed retrospectively.
Results
A total of 56 patients underwent TBC using a 1.1 mm cryoprobe for NGS testing, during the study period. Most patients (98%) were in the advanced stage of lung cancer (recurrent or inoperable disease of stages III or IV). The diagnostic yield of NGS for DNA and RNA sequencing was 95% each (53 of 56). Moderate bleeding was noted in three patients (5%) and none of the study patients developed life‐threatening complications, such as pneumothorax or lung infection.
Conclusion
TBC using a 1.1 mm‐diameter cryoprobe is a useful and safe tool for NGS analysis, for both DNA and RNA sequencing. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.
- Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
- Department of Radiology, Pusan National University School of Medicine, Busan, Republic of Korea.
- Department of Radiology, Pusan National University Hospital, Busan, Republic of Korea.
- GC Genome Corporation, Yongin, Republic of Korea.
ORCID-Profile: Min Ki Lee, Jung Seop Eom
Zitieren
APA
Kim, M. H., Kim, S. H., Lee, G., Mok, J., Lee, M. K., Song, J. S., & Eom, J. S. (2024). Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer. Respirology, 29(4), 333-339. https://doi.org/10.1111/resp.14680
Vancouver
Kim MH, Kim SH, Lee G, Mok J, Lee MK, Song JS, et al. Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer. Respirology. 2024;29(4):333-339. doi:10.1111/resp.14680
BibTeX
@article{Kim2024,
author = {Kim, Mi-Hyun and Kim, Soo Han and Lee, Geewon and Mok, Jeongha and Lee, Min Ki and Song, Ju Sun and Eom, Jung Seop},
title = {Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer},
journal = {Respirology},
year = {2024},
volume = {29},
number = {4},
pages = {333--339},
doi = {10.1111/resp.14680}
}
EUVIMED